权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular specification of dopaminergic neuron diversity

多巴胺能神经元多样性的分子规范

基本信息

批准号：
10585657
负责人：
Benjamin R Arenkiel
金额：
$ 59.37万
依托单位：
BAYLOR COLLEGE OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-02-01 至 2026-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10585657
关键词：
Adopted Basic Science Biochemical Biological Assay Biology Brain Brain region Catecholamines Cells Coupling Data Development Diabetic Retinopathy Disease Disease model Dopamine Dopaminergic Cell Endowment Etiology Eye Generations Genetic Goals Histologic Interneurons Lead Location Maps Mediating Mental disorders Midbrain structure Molecular Molecular Target Mus Neuromodulator Neurons Parkinson Disease Pathology Pathway interactions Pattern Phosphotransferases Play Population Production Property Protein-Serine-Threonine Kinases Public Health Regulation Retina Role STK11 gene Signal Transduction Specific qualifier value Substantia nigra structure System Testing Time Ventral Tegmental Area Viral Vision Visual Visual System Work cell type dopaminergic neuron gain of function improved outcome inhibitory neuron interest loss of function mutant nerve stem cell nervous system disorder neural neurogenetics neuron development neuron loss neuroregulation novel novel therapeutics preservation programs temporal measurement transcriptomics

项目摘要

PROJECT SUMMARY Dopamine is produced by a small but impactful subset of neurons in the eye and brain. Because this neuromodulator plays a critical role in a host of mental illnesses and diseases, it is vital to understand how dopamine neuron subsets are established and maintained. Our preliminary data show that the serine-threonine kinase LKB1 is required to restrict the number of dopaminergic neurons in the retina. In addition, we identify new dopaminergic cell subsets and show that LKB1 is cell-intrinsically required in inhibitory interneurons to modulate dopamine neuron diversity using molecular and neurogenetic approaches. This is a compelling result because factors that control the number and type of neurons that produce dopamine have remained elusive. To understand how LKB1 regulates dopamine neuron diversity, we have devised a strategy encompassing neural identity and connectivity mapping, cell-type specific intersectional genetic and viral strategies, molecular and biochemical studies, and functional analysis. We propose three aims. In Aim 1, we ask whether LKB1 is spatially and temporally sufficient to instruct dopamine neuron diversity by modulating this kinase in specific locations and at particular times. In Aim 2, we identify the mechanism through which LKB1 functions and test the hypothesis that LKB1-AMPK signaling plays a critical role. In Aim 3, we extend our analysis to the midbrain to test whether LKB1 is similarly required in this disease-relevant brain region to limit dopamine neuron diversity. Identifying a kinase pathway that precisely controls dopamine neuron diversity is surprising, so completing these aims will markedly advance our understanding of how dopaminergic neurons are endowed with their unique properties. In addition, these results will provide new therapeutic avenues for restoring dopamine production in the context of disease.

项目总结